Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of GX-E2 dosing and schedule in anemia due to chronic kidney disease on dialysis
KCT0001614Phase 2Completed
- Sponsor
- Ministry of Health & Welfare
- Start
- Aug 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of efepoetin alfa in Uraemic Anaemia, sponsored by Ministry of Health & Welfare. Started Aug 2014; status: completed.
02
Drugs
efepoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on KCT0001614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001614.